Gland Pharma Ltd. (GLAND)
Market Closed
12 Aug, 10:00
XNSE XNSE Primary MSE ₹
2,891. 20
-33.2
-1.1353%
₹
- Market Cap
- P/E Ratio
- Div Yield
732,462 Volume
- Eps
₹ 2,924.4
Previous Close Want to track GLAND and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Gland Pharma Ltd. (GLAND) Statistics
Valuation metrics
Market Cap -
Enterprise value 398.31B
Trailing P/E (ttm) 41.71
Forward P/E -
PEG ratio 0.89
Price/Sales (ttm) 6.67
Price/Book (mrq) 4.14
Enterprise Value/Revenue 6.19
Enterprise Value/EBITDA 20.85
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 530.39K
Average volume (90 days) 698.22K
Price summary
52-Week low 1,573.6
52-Week high 2,988.4
Beta -
50-Day moving average 2,450.17
200-Day moving average 2,027.83
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate 38
Trailing annual dividend yield 0.0146%
5-Year annual dividend yield -
Payout ratio 0.29
Dividend Date 27 Sep 2025
Ex-Dividend Date 14 Aug 2025
Last split factor -
Last split Date -
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin 0.16%
Operating margin 0.19%
Operational effectiveness
Return on assets 0.08%
Return on equity 0.11%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 390.39
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) 62.37
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 208.4
Total debt (mrq) -
Total Debt/Equity (mrq) 0.03
Current ratio (mrq) 4.68%
Book value per share (mrq) 628.81
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
